0001415889-22-000041.txt : 20220103 0001415889-22-000041.hdr.sgml : 20220103 20220103162034 ACCESSION NUMBER: 0001415889-22-000041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOTSON JERROLD DUANE CENTRAL INDEX KEY: 0001388853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 22502388 MAIL ADDRESS: STREET 1: 5 CENTERPOINTE DRIVE STREET 2: SUITE 400 CITY: LAKE OSWEGO STATE: OR ZIP: 97035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-577-3600 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 4 1 form4-01032022_010120.xml X0306 4 2021-12-31 0001411685 VistaGen Therapeutics, Inc. VTGN 0001388853 DOTSON JERROLD DUANE C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false VP, CFO AND SECRETARY Common Stock 2021-12-31 4 A 0 3575 1.6575 A 75821 D Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c) /s/ Jerrold D. Dotson 2022-01-03